Sotera Health Company
SHC
$11.50
$0.373.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -6.46% | 8.47% | 8.35% | 12.51% | 23.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.46% | 8.47% | 8.35% | 12.51% | 23.31% |
| Cost of Revenue | -3.32% | 8.75% | 7.01% | 10.98% | 18.46% |
| Gross Profit | -8.73% | 8.25% | 9.46% | 14.00% | 27.07% |
| SG&A Expenses | 5.14% | 18.00% | 8.55% | 8.27% | 14.29% |
| Depreciation & Amortization | -2.03% | -1.69% | -4.22% | -3.05% | 0.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.13% | 10.14% | 6.41% | 8.92% | 15.76% |
| Operating Income | -15.31% | 5.01% | 12.92% | 25.18% | 38.30% |
| Income Before Tax | -31.53% | 8,996.60% | -56.09% | 103.89% | 117.35% |
| Income Tax Expenses | 20.94% | 82.28% | -41.78% | 83.24% | 145.91% |
| Earnings from Continuing Operations | -68.14% | 224.44% | -62.77% | 122.48% | 112.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.14% | 224.44% | -62.77% | 122.48% | 112.10% |
| EBIT | -15.31% | 5.01% | 12.92% | 25.18% | 38.30% |
| EBITDA | -11.56% | 7.45% | 8.83% | 14.89% | 30.28% |
| EPS Basic | -68.18% | 223.46% | -62.86% | 121.78% | 112.02% |
| Normalized Basic EPS | -28.70% | 15.71% | -0.19% | -10.67% | 47.88% |
| EPS Diluted | -68.18% | 220.00% | -62.50% | 100.00% | 112.00% |
| Normalized Diluted EPS | -28.84% | 14.68% | 0.00% | -10.75% | 46.85% |
| Average Basic Shares Outstanding | 0.68% | 0.70% | 0.71% | 0.44% | 0.33% |
| Average Diluted Shares Outstanding | 0.87% | 1.59% | 0.49% | 0.38% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
